Stay updated on DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Sign up to get notified when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.
Latest updates to the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.3.3. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.1%
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedRevision note updated from v3.3.1 to v3.3.2. This appears to be a minor backend page update with no visible changes to study content or user actions.SummaryDifference0.0%
- Check33 days agoChange DetectedIPD data-sharing details were added (IPD Plan Description = Yes, with access via a data access agreement after publication). The study record also updated its status and timing fields to reflect completion.SummaryDifference0.6%
- Check40 days agoChange DetectedThe government funding/status notice on the page was removed. The study details, inclusion/exclusion criteria, and listed locations remain unchanged.SummaryDifference0.3%
- Check54 days agoChange DetectedNo meaningful differences were observed between the two screenshots; the Study Details page for NCT03469960 remains the same with identical sections and information.SummaryDifference0.3%
- Check83 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%
Stay in the know with updates to DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DICIPLE: Dual Checkpoint Inhibitors in NSCLC Clinical Trial page.